LabMedica

Download Mobile App
Recent News Expo
Medica 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Fapon Highlights Local Manufacturing Solutions and Recombinant QC Materials

By LabMedica International staff writers
Posted on 17 Nov 2026

Fapon (Dongguan, China) is showcasing its local manufacturing solutions and comprehensive in vitro diagnostics (IVD) portfolio at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. At Hall 3, Stand D95, the company is highlighting technologies and services designed to support localized diagnostic production, including integrated IVD solutions, recombinant quality control (QC) materials, and calibrator raw materials. These offerings aim to help diagnostic manufacturers strengthen local production capabilities and maintain reliable material supplies.

Local Manufacturing Solutions


Photo courtesy of Fapon
Photo courtesy of Fapon

Among the featured offerings are Fapon's Local Manufacturing Solutions, covering chemiluminescence immunoassays (CLIA), ELISA, clinical biochemistry, point-of-care testing (POCT), and molecular diagnostics. The solutions provide end-to-end technology transfer and localization support, including core raw materials, bulk reagents, custom development, manufacturing, and registration assistance. Through these services, Fapon helps diagnostic manufacturers establish or expand local production capabilities, from assay development to commercialization.

One-Stop IVD solutions

Fapon is also presenting its integrated IVD solutions, which combine diagnostic raw materials, reagent services, and open-system instruments. The company's capabilities encompass antibody discovery, process development, reagent formulation, and customization. Among the highlighted applications is a blood-based Alzheimer's disease testing solution, providing raw materials and bulk reagents for biomarkers including phosphorylated tau 217 (p-tau217), p-tau181, amyloid beta 40 (Aβ40), Aβ42, glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL). These materials support manufacturers developing blood-based assays for Alzheimer's disease.

Recombinant quality control (QC) and calibrator raw materials

Another key highlight is Fapon's recombinant QC and calibrator raw materials, developed to improve consistency and reduce supply variability associated with naturally sourced materials. Using recombinant expression technology, the materials are designed to provide high lot-to-lot consistency while minimizing biosafety risks. In application evaluations, rheumatoid factor (RF) dilution linearity demonstrated an R² value of 0.9989, while clinical comparison testing showed an R² value of 0.9924. The portfolio covers diagnostic markers including RF, C-reactive protein (CRP), creatine kinase-MB (CK-MB), HIV/HIV-p24, hepatitis B virus (HBV), and ToRCH, supporting clinical biochemistry, CLIA, ELISA, and POCT applications.

Fapon also offers flexible production volumes of 0.8, 2, 6, and 60 liters, using vessels of up to 200 liters, with batch sizes tailored to customer demand. Quarterly production cycles, available inventory, and overseas warehouses support material availability and distribution. Together, these capabilities reflect Fapon's focus on supporting diagnostic manufacturers through localized production, integrated development services, and reliable IVD raw material supply.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Urinalysis Solution
UN-9000
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®

Latest Medica 2026 News

Ozelle Presents AI-Assisted Hematology and Cell Morphology Analysis
16 Nov 2026  |   Medica 2026

Vircell Presents Automated Immunoassays and Molecular Diagnostics at MEDICA 2026
16 Nov 2026  |   Medica 2026

Sekisui Highlights Rapid Testing and Clinical Chemistry Solutions at MEDICA 2026
16 Nov 2026  |   Medica 2026